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aim: Ventricular arrhythmia (VA) is an important prognostic factor in hypertrophic obstructive cardiomyopathy (HOCM), but little is known about the 
effect of invasive treatment (PTSMA:percutaneous transluminal septal myocardial ablation, and myotomy) on VA recurrence. We therefore attempted 
to analyze the relationship of arrhythmogenic substrate evaluated by late-gadrinium enhancement (LGE) cardiac magnetic resonance (CMR) and VA 
occurrence in HOCM patients.
Methods and results: Forty-two patients who underwent PTSMA and 13 patients who underwent myotomy at the National Cerebral and 
Cardiovascular Center from January 1999 to May 2013 were enrolled (mean age: 62.7 years old, female rate: 63.6%, mean observation period: 58.6 
months). Mean pressure gradient (PG) change by the invasive treatment was −68.0 mmHg in PTSMA group and −97.7 mmHg in myotomy group. PG 
with 50 mmHg or greater remained in 8 PTSMA patients (19.0%) and 1 myotomy patient (7.7%). Pre/postoperative VA were seen in 17 (40.4%) /8 
(19.0%) patients in PTSMA group and 5 (38.5%) / 1 (7.7%) patient in myotomy group. Semi-automated quantitative evaluation of late-gadolinium-
enhancement (LGE) cardiac magnetic resonance (CMR) was also conducted in 25 PTSMA and 7 myotomy patients. ≥2SD and ≥5SD above the 
mean signal of reference myocardium was determined as gray-zone and core scar mass. The patients, who experienced VA at least once (n=10), 
had higher LGE (mean gray/core/gray+core: 18.5%/16.0%/32.4%) compared with those in the patients without VA (n=21) (gray/core/gray+core: 
5.4%/3.1%/8.1%). There was a strong correlation between LGE volume/weight ratio and degree of VA (R=gray/core/gray+core: 0.83/0.73/0.80, 
p<0.001).
conclusions: The results of the present study revealed that both PTSMA and myectomy improved the PG and decreased the VA. In addition, life-
threatening VA occurrence correlated with the extent of LGE-CMR. Quantitative evaluation of myocardium damage with LGE-CMR can be effective for 
the prediction of VA and give us strategy in invasive treatment in patients with HOCM.
